Login / Signup

Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action.

Amaury E Fernández-MontalvánMarkus BergerBenno KuropkaSeong Joo KooVolker BadockJoerg WeiskeVera PuetterSimon J HoltonDetlef StöckigtAntonius Ter LaakPaolo A CentrellaMatthew A ClarkChristoph E DumelinEric A SigelHolly H SoutterDawn M TroastYing ZhangJohn W CuozzoAnthony D KeefeDidier RocheVincent RodeschiniApirat ChaikuadLaura Díaz-SáezJames M BennettOleg FedorovKilian V M HuberJan HübnerHilmar WeinmannIngo V HartungMátyás Gorjánácz
Published in: ACS chemical biology (2017)
ATAD2 (ANCCA) is an epigenetic regulator and transcriptional cofactor, whose overexpression has been linked to the progress of various cancer types. Here, we report a DNA-encoded library screen leading to the discovery of BAY-850, a potent and isoform selective inhibitor that specifically induces ATAD2 bromodomain dimerization and prevents interactions with acetylated histones in vitro, as well as with chromatin in cells. These features qualify BAY-850 as a chemical probe to explore ATAD2 biology.
Keyphrases